Double primary epidermoid carcinoma of the vulva and cervix
dc.contributor.author | Choo, Yew Cheong | en_US |
dc.contributor.author | Morley, George W. | en_US |
dc.date.accessioned | 2006-04-07T17:24:18Z | |
dc.date.available | 2006-04-07T17:24:18Z | |
dc.date.issued | 1980-06 | en_US |
dc.identifier.citation | Choo, Yew Cheong, Morley, George W. (1980/06)."Double primary epidermoid carcinoma of the vulva and cervix." Gynecologic Oncology 9(3): 324-333. <http://hdl.handle.net/2027.42/23231> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6WG6-4C52K6M-28/2/6fcc0f1d3b1b885e39bddf7ecb27e441 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/23231 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6991376&dopt=citation | en_US |
dc.description.abstract | A retrospective study was undertaken on patients with multiprimaries associated with vulva carcinoma, analyzing in particular 33 patients with double epidermoid primaries of the vulva and cervix. It is noted that 20.8% of patients with vulvar carcinoma had a second primary; this occurred more frequently in intraepithelial (33.3%) than in invasive (16.0%) vulvar carcinoma. While the commonest second primary is located in the cervix, this association appears significant only in patients with intraepithelial (22.5%), but not in invasive (7.9%), vulvar carcinoma. The incidences previously reported in the literature are also reviewed for comparison. | en_US |
dc.format.extent | 653854 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Double primary epidermoid carcinoma of the vulva and cervix | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Otolaryngology | en_US |
dc.subject.hlbsecondlevel | Ophthalmology | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan Hospital, Ann Arbor, Michigan 48109, U.S.A. | en_US |
dc.contributor.affiliationum | Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan Hospital, Ann Arbor, Michigan 48109, U.S.A. | en_US |
dc.identifier.pmid | 6991376 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/23231/1/0000164.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0090-8258(80)90044-X | en_US |
dc.identifier.source | Gynecologic Oncology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.